⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24697342 | 0.72 | KMT2A (0.41) | — | |
| SCHEMBL24696850 | 0.71 | — | — | |
| SCHEMBL24696665 | 0.64 | KMT2A (0.36) | — | |
| SCHEMBL24696470 | 0.62 | KDM4E (0.39) | — | |
| SCHEMBL24696471 | 0.60 | — | — | |
| SCHEMBL24696846 | 0.59 | CYP2A6 (0.37) | — | |
| SCHEMBL24697319 | 0.58 | IDO1 (0.35) | — | |
| SCHEMBL24696866 | 0.57 | KDM4E (0.42) | — | |
| SCHEMBL13711150 | 0.55 | TSHR (0.50) | — | |
| SCHEMBL5547607 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022254027-A1 | 3-PYRROLYLSULFONAMIDE COMPOUNDS AS GPR17 ANTAGONISTS | REWIND THERAPEUTICS NV (BE) | 2022-12-08 | — | — | WO | disclosed |